These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32008073)

  • 1. A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?
    Katsari M; Kasselimis DS; Giogkaraki E; Breza M; Evangelopoulos ME; Anagnostouli M; Andreadou E; Kilidireas C; Hotary A; Zalonis I; Koutsis G; Potagas C
    J Neurol; 2020 May; 267(5):1464-1475. PubMed ID: 32008073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
    Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
    Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
    Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
    Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
    Okada K; Kakeda S; Tahara M
    Mult Scler Relat Disord; 2020 Feb; 38():101507. PubMed ID: 31766000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
    Rojas JI; Murphy G; Sanchez F; Patrucco L; Fernandez MC; Miguez J; Funes J; Golimstok A; Cristiano E
    Neuroradiol J; 2018 Aug; 31(4):350-355. PubMed ID: 29869576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
    Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
    Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecological impact of isolated cognitive relapses in MS.
    Meli R; Roccatagliata L; Capello E; Bruschi N; Uccelli A; Mancardi G; Inglese M; Pardini M
    Mult Scler; 2020 Jan; 26(1):114-117. PubMed ID: 30430928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
    Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
    Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
    Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
    Pitteri M; Romualdi C; Magliozzi R; Monaco S; Calabrese M
    Mult Scler; 2017 May; 23(6):848-854. PubMed ID: 27527906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS.
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2020 Nov; 46():102577. PubMed ID: 33296975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study.
    Amato MP; Razzolini L; Goretti B; Stromillo ML; Rossi F; Giorgio A; Hakiki B; Giannini M; Pastò L; Portaccio E; De Stefano N
    Neurology; 2013 May; 80(19):1728-33. PubMed ID: 23576622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.